Why has Binswanger's disease been called into question?

Prepare for the American Board of Professional Psychology (ABPP) Exam with flashcards and multiple-choice questions. Each question includes insights and explanations to help you excel. Get ready for your certification journey!

Multiple Choice

Why has Binswanger's disease been called into question?

The main idea being tested is the difficulty of defining Binswanger's disease as a distinct condition when similar imaging findings appear in people without the disease. Binswanger's disease is classically described as a subcortical vascular dementia with widespread, chronic small-vessel disease causing extensive white matter (periventricular and deep) damage. However, similar white matter changes are common in aging and in various vascular or other nonspecific conditions. Seeing white matter abnormalities on brain imaging does not reliably distinguish Binswanger's disease from normal aging or other causes of leukoaraiosis, which has led clinicians and researchers to question whether it represents a unique, well-defined syndrome. This lack of imaging specificity is the core reason the diagnosis has been called into question. Other options don’t address this diagnostic ambiguity as directly. For example, lacunar infarcts do not typically “heal” in a way that would define or debunk the disease, and cognitive impairment with periventricular white matter loss can occur with many forms of vascular or neurodegenerative aging, not uniquely with Binswanger's. Claiming that the disease is well established would actually argue against it being questionable rather than explain why it is questioned.

The main idea being tested is the difficulty of defining Binswanger's disease as a distinct condition when similar imaging findings appear in people without the disease. Binswanger's disease is classically described as a subcortical vascular dementia with widespread, chronic small-vessel disease causing extensive white matter (periventricular and deep) damage. However, similar white matter changes are common in aging and in various vascular or other nonspecific conditions. Seeing white matter abnormalities on brain imaging does not reliably distinguish Binswanger's disease from normal aging or other causes of leukoaraiosis, which has led clinicians and researchers to question whether it represents a unique, well-defined syndrome. This lack of imaging specificity is the core reason the diagnosis has been called into question.

Other options don’t address this diagnostic ambiguity as directly. For example, lacunar infarcts do not typically “heal” in a way that would define or debunk the disease, and cognitive impairment with periventricular white matter loss can occur with many forms of vascular or neurodegenerative aging, not uniquely with Binswanger's. Claiming that the disease is well established would actually argue against it being questionable rather than explain why it is questioned.

More practice questions